All In Biotech

Drug Trial Radar · NCT00689117

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of CT Gel in Subjects With Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: May 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,649 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,649

Actual

Start

Apr 2008

Primary completion

Apr 2009

Study completion May 2009

Sponsor

Lead sponsor
Stiefel, a GSK CompanyIndustry
Sponsor type
Industry
Collaborators
GlaxoSmithKline
First posted
Jun 3, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate the safety and effectiveness of CT Gel in subjects with acne vulgaris. The hypothesis is that CT Gel is superior to Clindamycin Gel, Tretinoin Gel and Vehicle Gel for the treatment of acne vulgaris.

Conditions

  • Acne Vulgaris
  • Acne

Interventions

  • CT GelDrug

    Topical gel consisting of clindamycin 1% and tretinoin 0.025%, applied once daily in the evening for 12 weeks

  • Clindamycin Gel (clindamycin )Drug

    Clindamycin 1% gel applied topically once daily in the evening for 12 weeks

  • Tretinoin Gel (tretinoin)Drug

    Tretinoin 0.025% gel applied topically once daily in the evening for 12 weeks

  • Vehicle GelDrug

    Topical gel without clindamycin or tretinoin applied topically once daily in the evening for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute Change From Baseline in Lesion Counts (Total, Inflammatory, and Non-inflammatory) at Week 12 (End of Study)Time frame: Baseline, Week 12
  2. The Percentage of Participants Who Had a Minimum 2-grade Improvement in the Investigator's Static Global Assessment (ISGA) Score From Baseline to Week 12Time frame: Baseline, Week 12

Locations

32 sites in 3 countries. Site status is shown where the registry gives one.

  • Radiant Research

    Birmingham, Alabama

  • Coastal Clinical Research, Inc.

    Mobile, Alabama

  • Burke Pharmaceutical Research

    Hot Springs, Arkansas

  • Center for Dermatology, Cosmetic and Laser Surgery

    Fremont, California

  • University Clinical Trials

    San Diego, California

  • Longmont Medical Research Network

    Longmont, Colorado

  • FXM Research Corporation

    Miami, Florida

  • FXM Research - Miramar

    Miramar, Florida

  • Advanced Dermatolgy & Cosemtic Surgery

    Ormond Beach, Florida

  • Dermatology Specialists

    Louisville, Kentucky

  • Massachusettes General Hospital - Clinical Unit for Research Trials in Skin

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Henry Ford Medical Center

    Detroit, Michigan

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • Skin Specialists, P.C.

    Omaha, Nebraska

  • Academic Dermatology Research

    Albuquerque, New Mexico

  • Dermatology Research Associates, Inc.

    Cincinnati, Ohio

  • Yardley Dermatology Associates

    Yardley, Pennsylvania

  • Clinical Partners, LLC

    Johnston, Rhode Island

  • Dermatology Associates of Knoxville, P.C.

    Knoxville, Tennessee

  • Tennessee Clinical Research

    Nashville, Tennessee

  • DermResearch, Inc.

    Austin, Texas

  • J & S Studies, Inc.

    College Station, Texas

  • The Hair and Skin Research Treatment Center

    Dallas, Texas

  • Dermatology Research Center, Inc.

    Salt Lake City, Utah

  • Premier Clincial Research

    Spokane, Washington

  • Advanced Healthcare

    Milwaukee, Wisconsin

  • Dermatology And Skin Centre

    Belize City, Belize

  • Dr. Moguel's Clinic

    Belize City, Belize

  • K. Papp Clinical Research, Inc.

    Waterloo, Ontario, Canada

  • Windsor Clinical Research Center, Inc.

    Windsor, Ontario, Canada

  • Innovaderm Research, Inc.

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.